Zenas Biopharma Inc
Zenas Biopharma Inc (ZBIO) Straddle
ZBIO straddle scan found 37 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 60.7%.
Read more
Trading a ZBIO straddle lets you take a pure volatility position on Zenas Biopharma Inc without committing to a direction. Zenas Biopharma Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ZBIO straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on ZBIO profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Zenas Biopharma Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ZBIO straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody for various indications, including immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody.
Zenas BioPharma, Inc. was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is based in Waltham, Massachusetts.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the ZBIO straddle is the cleanest expression of that view. Our scanner prices every ZBIO straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ZBIO straddle into a catalyst or short a ZBIO straddle to harvest decay, the options straddle setups that matter are all in one place.
| Dec 17, 2027 | 45.00 | $25.50 | 450 | 17% | 60.7% | $70.50 | $19.50 | 0 |
| Jan 15, 2027 | 40.00 | $13.30 | 114 | 17% | 59.0% | $53.30 | $26.70 | 0 |
| May 21, 2027 | 45.00 | $21.25 | 240 | 17% | 58.7% | $66.25 | $23.75 | 0 |
| Dec 17, 2027 | 40.00 | $22.50 | 450 | 17% | 58.5% | $62.50 | $17.50 | 0 |
| Mar 19, 2027 | 45.00 | $19.43 | 177 | 17% | 58.3% | $64.43 | $25.58 | 0 |
| Feb 19, 2027 | 40.00 | $14.98 | 149 | 17% | 57.7% | $54.98 | $25.03 | 0 |
| Feb 19, 2027 | 45.00 | $18.75 | 149 | 17% | 57.5% | $63.75 | $26.25 | 0 |
| May 21, 2027 | 40.00 | $18.05 | 240 | 17% | 57.3% | $58.05 | $21.95 | 0 |
| Feb 19, 2027 | 35.00 | $12.28 | 149 | 17% | 56.2% | $47.28 | $22.73 | 0 |
| Jan 15, 2027 | 45.00 | $18.18 | 114 | 17% | 55.3% | $63.18 | $26.83 | 0 |
As of September 24, 2026
Find the right straddle before volatility moves
Track ZBIO straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→